Open AccessImprovement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
Author(s) -
Alfredomaria Lurati,
Antonella Laria,
D. Mazzocchi,
Katia Angela Re,
Maria Grazia Marrazza,
Paola Faggioli,
A. Mazzone
Publication year - 2021
Publication title -
open access rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.63
H-Index - 14
ISSN - 1179-156X
DOI - 10.2147/oarrr.s302679
Subject(s) - medicine , golimumab , adalimumab , rheumatoid arthritis , etanercept , concomitant , glycated hemoglobin , tocilizumab , infliximab , type 2 diabetes mellitus , statistical significance , diabetes mellitus , glycemic , type 2 diabetes , insulin , endocrinology , tumor necrosis factor alpha
The aim of our study was to evaluate the possible role of biological treatments for rheumatoid arthritis (RA) in improving the glycemic profile in patients affected not only by RA but also by type 2 diabetes mellitus (2TDM).